We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
Read MoreHide Full Article
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
One stock to keep an eye on is Zimmer Biomet (ZBH - Free Report) . ZBH is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 11.98, while its industry has an average P/E of 15.93. ZBH's Forward P/E has been as high as 13.52 and as low as 10.73, with a median of 12.36, all within the past year.
Another valuation metric that we should highlight is ZBH's P/B ratio of 1.58. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks solid versus its industry's average P/B of 2.35. Over the past 12 months, ZBH's P/B has been as high as 1.82 and as low as 1.43, with a median of 1.66.
Finally, investors should note that ZBH has a P/CF ratio of 10.65. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 13.02. Within the past 12 months, ZBH's P/CF has been as high as 11.88 and as low as 9.36, with a median of 10.65.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Zimmer Biomet is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, ZBH feels like a great value stock at the moment.
View the Zacks #1 Rank List
Image: Bigstock
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
One stock to keep an eye on is Zimmer Biomet (ZBH - Free Report) . ZBH is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock holds a P/E ratio of 11.98, while its industry has an average P/E of 15.93. ZBH's Forward P/E has been as high as 13.52 and as low as 10.73, with a median of 12.36, all within the past year.
Another valuation metric that we should highlight is ZBH's P/B ratio of 1.58. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This stock's P/B looks solid versus its industry's average P/B of 2.35. Over the past 12 months, ZBH's P/B has been as high as 1.82 and as low as 1.43, with a median of 1.66.
Finally, investors should note that ZBH has a P/CF ratio of 10.65. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 13.02. Within the past 12 months, ZBH's P/CF has been as high as 11.88 and as low as 9.36, with a median of 10.65.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Zimmer Biomet is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, ZBH feels like a great value stock at the moment.